Fourth Affiliated Hospital of Harbin Medical University
In research, Fourth Affiliated Hospital of Harbin Medical University stands highest in Medicine (#3,317 of 10,443 worldwide), Health Sciences (#4,565 of 11,982 worldwide) and Life Sciences (#3,040 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research and Pulmonary and Respiratory Medicine — Cancer Research is 14.6× its share of world research.
- World rank, 2022–2025
- #6,155 of 28,054 · #12,230 all time
- Rank in China
- #1,290 of 3,058
- Research works
- 1.2k ▼ 3% vs 2013–17
- Citations
- 19k 16.3 per fractional work
- Top-10% rate
- 23.6% record average 16.5%
- Open access
- 47% world 28%
What is Fourth Affiliated Hospital of Harbin Medical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,317 of 10,443 | 24.8% | 162 | #7273 | |
| Health SciencesDomain | #4,565 of 11,982 | 24.6% | 169 | #8535 | |
| Life SciencesDomain | #3,040 of 7,800 | 21.5% | 111 | #5602 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,356 of 3,579 | 21.1% | 80 | #4723 |
Each strip is that field’s whole ranked pool, with the notch where Fourth Affiliated Hospital of Harbin Medical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#7,273 #3,317
- Health Sciences#8,535 #4,565
- Life Sciences#5,602 #3,040
- Biochemistry, Genetics and Molecular Biology#4,723 #2,356
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Fourth Affiliated Hospital of Harbin Medical University specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 14.6× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 20.5 works15×
- Pulmonary and Respiratory MedicineSubfield · 24.8 works5.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.7×
- Immunology and Microbiology 4.3×
- Medicine 2.6×
- Neuroscience 2.6×
- Nursing 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Materials Science 0.8×
- Dentistry 0.8×
- Chemistry 0.5×
- Health Professions 0.4×
- Economics, Econometrics and Finance 0.4×
- Psychology 0.3×
- Physics and Astronomy 0.2×
- Engineering 0.2×
- Computer Science 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Energy 0.1×
- Decision Sciences 0.1×
- Mathematics 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.0×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at Fourth Affiliated Hospital of Harbin Medical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Gene Expression, Tumor Microenvironment, Cell Death, Biomarkers and Metastasis.
- Tumor Targeting
- Disease
- Neuroinflammation
- Clinical Practice Guidelines
- Apoptosis
- RNA Regulation
- Innate Immunity
- Neurodegeneration
- Cancer Therapy
- Cell Differentiation
- Immunotherapy
- Chemotherapy
- GPX4
- Lipid Peroxidation
- Biogenesis
- Regulation
- Biomarkers
- Epidemiology
- Gene Expression
- Inflammation
- Cancer
- Oxidative Stress
- Tumor Microenvironment
- Cell Death
- Cardiovascular Disease
- Metastasis
- Metabolic Syndrome
- Ferroptosis
- Obesity
- Epigenetic Regulation
- Angiogenesis
- Immunity
- Cytokines
- Heart Failure
- Long Noncoding RNAs
- Reactive Oxygen Species
- Cancer Progression
- Atherosclerosis
- Insulin Resistance
- Cancer Biomarkers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer48▲ 11×43 topics
- Inflammation38▲ 5.7×73 topics
- Oxidative Stress31▲ 5.8×45 topics
- Gene Expression23▲ 12×13 topics
- Tumor Microenvironment19▲ 14×8 topics
- Epidemiology16▲ 1.22×63 topics
- Cell Death15▲ 21×6 topics
- Biomarkers14▲ 6.1×17 topics
- Cardiovascular Disease13▲ 3.6×31 topics
- Regulation12▲ 7.0×10 topics
- Metastasis12▲ 11×10 topics
- Biogenesis12▲ 20×3 topics
- Metabolic Syndrome12▲ 4.4×19 topics
- Lipid Peroxidation11▲ 33×2 topics
- Ferroptosis11▲ 45×1 topic
- GPX411▲ 45×1 topic
- Obesity10▲ 4.1×16 topics
- Chemotherapy10▲ 4.4×17 topics
- Epigenetic Regulation10▲ 14×4 topics
- Immunotherapy10▲ 4.2×12 topics
- Angiogenesis9▲ 8.3×15 topics
- Cell Differentiation8▲ 28×2 topics
- Immunity8▲ 6.2×9 topics
- Cancer Therapy8▲ 4.3×17 topics
- Cytokines8▲ 8.6×8 topics
- Neurodegeneration8▲ 8.1×8 topics
- Heart Failure8▲ 5.5×11 topics
- Innate Immunity8▲ 7.5×11 topics
- Long Noncoding RNAs8▲ 28×1 topic
- RNA Regulation8▲ 22×1 topic
- Reactive Oxygen Species8▲ 6.0×10 topics
- Apoptosis8▲ 7.8×16 topics
- Cancer Progression8▲ 13×7 topics
- Clinical Practice Guidelines8▲ 4.3×13 topics
- Atherosclerosis7▲ 8.1×10 topics
- Neuroinflammation7▲ 8.0×6 topics
- Insulin Resistance7▲ 4.8×9 topics
- Disease7▲ 24×3 topics
- Cancer Biomarkers6▲ 22×3 topics
- Tumor Targeting6▲ 10×3 topics
Which research topics does Fourth Affiliated Hospital of Harbin Medical University publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Circular RNAs in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 11 works
- 2 Cancer-related molecular mechanisms research Cancer Research 8 works
- 3 MicroRNA in disease regulation Cancer Research 5 works
- 4 Circular RNAs in diseases Molecular Biology 4 works
- 5 RNA modifications and cancer Molecular Biology 4 works
- 6 Nanoplatforms for cancer theranostics Biomedical Engineering 4 works
- 7 Cancer, Lipids, and Metabolism Cancer Research 3 works
- 8 Neuroinflammation and Neurodegeneration Mechanisms Neurology 3 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fourth Affiliated Hospital of Harbin Medical University's research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Harbin
- Harbin Institute of Technology
- Harbin Engineering University
- Northeast Forestry University
- Northeast Agricultural University
- Harbin Medical University
- Harbin University of Science and Technology
- Heilongjiang University
- Harbin University of Commerce
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.